17-alpha-hydroxyprogesterone has been researched along with Cancer of Pituitary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Husager, L; Laurberg, P; Møller, J; Weeke, J | 1 |
| Baumann, JB; Eberle, AN; Girard, J | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Cancer of Pituitary
| Article | Year |
|---|---|
Evaluation of pituitary-adrenal function after pituitary surgery.
Topics: 17-alpha-Hydroxyprogesterone; Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Cortodoxone; Craniopharyngioma; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Metyrapone; Middle Aged; Pituitary Neoplasms; Pituitary-Adrenal System; Risk | 1985 |
Plasma ACTH in diagnosis and control of adrenal disorders.
Topics: 17-alpha-Hydroxyprogesterone; Adenoma; Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Child; Cortodoxone; Cushing Syndrome; Humans; Hydrocortisone; Hydroxyprogesterones; Metyrapone; Pituitary Neoplasms | 1986 |